The No Red Tape For Addiction Treatment Act requires state Medicaid programs to cover at least one formulation of each medication used to treat opioid use disorder without requiring prior authorization or restricting dosage amounts. The bill specifically requires that at least one formulation of each drug be available in a long-lasting, injectable form if such a version exists. The law takes effect one year after enactment, though states that need to change their laws to comply have additional time until the first regular legislative session after the bill becomes law. The legislation also directs the Medicaid and CHIP Payment and Access Commission to report within one year on how states currently use restrictions on addiction treatment medications and what barriers patients and doctors face in accessing these treatments.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.